Literature DB >> 24677342

Identification of novel transcription factors in osteoclast differentiation using genome-wide analysis of open chromatin determined by DNase-seq.

Kazuki Inoue1, Yuuki Imai.   

Abstract

Clarification of the mechanisms underlying osteoclast differentiation enables us to understand the physiology of bone metabolism as well as the pathophysiology of bone diseases such as osteoporosis. Recently, it has been reported that epigenetics can determine cell fate and regulate cell type-specific gene expression. However, little is known about epigenetics during osteoclastogenesis. To reveal a part of epigenetics, especially focused on chromatin dynamics, during early osteoclastogenesis and to identify novel transcription factors involved in osteoclastogenesis, we performed a genome-wide analysis of open chromatin during receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis using DNase I hypersensitive sites sequencing (DNase-seq). DNase-seq was performed using the extracted nuclei from RAW264 cells treated with or without RANKL for 24 hours, followed by several bioinformatic analyses. DNase I hypersensitive sites (DHSs) were dynamically changed during RANKL-induced osteoclastogenesis and they accumulated in promoter regions. The distributions of DHSs among cis-regulatory DNA regions were identical regardless of RANKL stimulation. Motif discovery analysis successfully identified well-known osteoclastogenic transcription factors including Jun, CREB1, FOS, ATF2, and ATF4, but also novel transcription factors for osteoclastogenesis such as Zscan10, Atf1, Nrf1, and Srebf2. siRNA knockdown of these identified novel transcription factors impaired osteoclastogenesis. Taken together, DNase-seq is a useful tool for comprehension of epigenetics, especially chromatin dynamics during osteoclastogenesis and for identification of novel transcription factors involved in osteoclastogenesis. This study may reveal underlying mechanisms that determine cell type-specific differentiation of bone cells and may lead to investigation of novel therapeutic targets for osteoporosis.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  DNASE-SEQUENCE; EPIGENETICS; OSTEOCLAST DIFFERENTIATION; OSTEOCLASTS; TRANSCRIPTION FACTORS

Mesh:

Substances:

Year:  2014        PMID: 24677342     DOI: 10.1002/jbmr.2229

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

1.  ZSCAN10 promotes cell proliferation, upregulates OCT4 expression, and activates Wnt/β-catenin signaling in glioma.

Authors:  Yuan Jiang; Hongming Huang; Xingen Zhu; Miaojing Wu; Minhua Ye; Bing Xiao; Cong Yu; Hua Fang; Feng Liu; Shigang Lv
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

Review 2.  Epigenetic regulation of bone cells.

Authors:  Kyung Hyun Park-Min
Journal:  Connect Tissue Res       Date:  2016-04-14       Impact factor: 3.417

3.  Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss.

Authors:  Zu-Guo Zheng; Hui-Min Cheng; Ya-Ping Zhou; Si-Tong Zhu; Pyone Myat Thu; Hui-Jun Li; Ping Li; Xiaojun Xu
Journal:  Cell Death Differ       Date:  2020-01-06       Impact factor: 15.828

4.  EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic Targets.

Authors:  Juraj Adamik; Sree H Pulugulla; Peng Zhang; Quanhong Sun; Konstantinos Lontos; David A Macar; Philip E Auron; Deborah L Galson
Journal:  J Bone Miner Res       Date:  2019-10-23       Impact factor: 6.741

5.  Genome-Wide Chromatin Landscape Transitions Identify Novel Pathways in Early Commitment to Osteoblast Differentiation.

Authors:  Bethtrice Thompson; Lyuba Varticovski; Songjoon Baek; Gordon L Hager
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

6.  Anti-inflammatory effect of Vaccinium oldhamii stems through inhibition of NF-κB and MAPK/ATF2 signaling activation in LPS-stimulated RAW264.7 cells.

Authors:  Ha Na Kim; Jueng Kyu Baek; Su Bin Park; Jeong Dong Kim; Ho-Jun Son; Gwang Hun Park; Hyun Ji Eo; Jae Ho Park; Hyuk-Sang Jung; Jin Boo Jeong
Journal:  BMC Complement Altern Med       Date:  2019-11-04       Impact factor: 3.659

7.  Transcription Factor KLF7 Promotes Osteoclast Differentiation by Suppressing HO-1.

Authors:  Changhong Chen; Fei Hu; Shichang Miao; Liping Sun; Yajun Jiao; Mingwei Xu; Xin Huang; Ying Yang; Rongkui Zhou
Journal:  Front Genet       Date:  2022-03-28       Impact factor: 4.599

8.  Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated.

Authors:  Candelaria Bracalente; Irene L Ibañez; Ariel Berenstein; Cintia Notcovich; María B Cerda; Fabio Klamt; Ariel Chernomoretz; Hebe Durán
Journal:  Oncotarget       Date:  2016-07-05

9.  Roles of Enhancer RNAs in RANKL-induced Osteoclast Differentiation Identified by Genome-wide Cap-analysis of Gene Expression using CRISPR/Cas9.

Authors:  Yukako Sakaguchi; Keizo Nishikawa; Shigeto Seno; Hideo Matsuda; Hiroshi Takayanagi; Masaru Ishii
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

10.  Comprehensive Analysis of the Genetic and Epigenetic Mechanisms of Osteoporosis and Bone Mineral Density.

Authors:  Hui Dong; Wenyang Zhou; Pingping Wang; Enjun Zuo; Xiaoxia Ying; Songling Chai; Tao Fei; Laidi Jin; Chen Chen; Guowu Ma; Huiying Liu
Journal:  Front Cell Dev Biol       Date:  2020-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.